Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer

被引：11
|
作者：
Zhang, Qiangsheng [1 ,2 ,3 ]
Hu, Xi [1 ,2 ,3 ]
Wan, Guoquan [1 ,2 ,3 ]
Wang, Jia [1 ,2 ,3 ]
Li, Lu [1 ,2 ,3 ]
Wu, Xiuli [1 ,2 ,3 ]
Liu, Zhihao [1 ,2 ,3 ]
Yu, Luoting [1 ,2 ,3 ]
机构：
[1] Sichuan Univ, West China Med Sch, West China Hosp, State Key Lab Biotherapy, 17 3rd Sect,Ren Min South Rd, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Med Sch, West China Hosp, Canc Ctr, 17 3rd Sect,Ren Min South Rd, Chengdu 610041, Sichuan, Peoples R China
[3] Collaborat Innovat Ctr Biotherapy, 17 3rd Sect,Ren Min South Rd, Chengdu 610041, Sichuan, Peoples R China
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2019年 / 184卷
关键词：
Microtubule; Tubulin polymerization inhibitors; Anti-cancer agents; Colorectal carcinoma; BIOLOGICAL EVALUATION; CELL-GROWTH; POTENT; DESIGN; ANALOGS; TARGET; IDENTIFICATION; MICROTUBULES; RESISTANCE; PURINES;
D O I：
10.1016/j.ejmech.2019.111728
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A new series of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives were designed, synthesized and demonstrated to act as tubulin polymerization inhibitors. These new derivatives showed significant antitumor activities, among which SKLB0533 demonstrated to be the most potent compound, with IC50 values ranging from 44.5 to 135.5 nM against seven colorectal carcinoma (CRC) cell lines. Remarkably, SKLB0533 exhibited no activity against other potential targets, such as 420 kinases and EZH2. Besides, SKLB0533 inhibited tubulin polymerization, arrested the cell cycle at the G2/M phase and induced apoptosis in CRC cells. Furthermore, SKLB0533 suppressed tumour growth in the HCT116 xenograft model without inducing notable major organ-related toxicity, suggesting that SKLB0533 could be used as a promising lead compound for the development of new antitumor agents. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数：16
相关论文
共 50 条
  • [21] Discovery of (Z)-1-(3-((1H-Pyrrol-2-yl)methylene)-2-oxoindolin-6-yl)-3-(isoxazol-3-yl)urea Derivatives as Novel and Orally Highly Effective CSF-1R Inhibitors for Potential Colorectal Cancer Immunotherapy
    Lv, Qi
    Pan, Xiang
    Wang, Dan
    Rong, Quanjin
    Ma, Ben
    Xie, Xiaolong
    Zhang, Yinan
    Wang, Junwei
    Hu, Lihong
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (23) : 17184 - 17208
  • [22] The Discovery of PLK4 Inhibitors: (E)-3-((1H-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents
    Laufer, Radoslaw
    Forrest, Bryan
    Li, Sze-Wan
    Liu, Yong
    Sampson, Peter
    Edwards, Louise
    Lang, Yunhui
    Awrey, Donald E.
    Mao, Guodong
    Plotnikova, Olga
    Leung, Genie
    Hodgson, Richard
    Beletskaya, Irina
    Mason, Jacqueline M.
    Luo, Xunyi
    Wei, Xin
    Yao, Yi
    Feher, Miklos
    Ban, Fuqiang
    Kiarash, Reza
    Green, Erin
    Mak, Tak W.
    Pan, Guohua
    Pauls, Henry W.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (15) : 6069 - 6087
  • [23] Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors
    Liang, Tingting
    Zhou, Xiaomin
    Lu, Lu
    Dong, Haiyang
    Zhang, Yanan
    Xu, Yungen
    Qi, Jianguo
    Zhang, Yahong
    Wang, Jianhong
    BIOORGANIC CHEMISTRY, 2021, 110
  • [24] Discovery of 1-{(3R,4R)-3[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants
    Cheng, Hengmiao
    Nair, Sajiv K.
    Murray, Brion W.
    Almaden, Chau
    Bailey, Simon
    Baxi, Sangita
    Behenna, Doug
    Cho-Schultz, Sujin
    Dalvie, Deepak
    Dinh, Dac M.
    Edwards, Martin P.
    Feng, Jun Li
    Ferre, Rose Ann
    Gajiwala, Ketan S.
    Hemkens, Michelle D.
    Jackson-Fisher, Amy
    Jalaie, Mehran
    Johnson, Ted O.
    Kania, Robert S.
    Kephart, Susan
    Lafontaine, Jennifer
    Lunney, Beth
    Liu, Kevin K-C.
    Liu, Zhengyu
    Matthews, Jean
    Nagata, Asako
    Niessen, Sherry
    Ornelas, Martha A.
    Orr, Suvi T. M.
    Pairish, Mason
    Planken, Simon
    Ren, Shijian
    Richter, Daniel
    Ryan, Kevin
    Sach, Neal
    Shen, Hong
    Smeal, Tod
    Solowiej, Jim
    Sutton, Scott
    Tran, Khanh
    Tseng, Elaine
    Vemier, William
    Walls, Marlena
    Wang, Shuiwang
    Weinrich, Scott L.
    Xin, Shuibo
    Xu, Haiwei
    Yin, Min-Jean
    Zientek, Michael
    Zhou, Ru
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 2005 - 2024
  • [25] The crystal structure of 3-(6-fluoro-1H-indol-3-yl)-1-methylquinoxalin-2(1H)-one, C17H12FN3O
    Ni, Hang-Cheng
    Zhao, Min
    Li, Wen-An
    Liu, Zhen-Xiang
    Shao, Ling-Li
    Chen, Miao-Miao
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2024, 239 (05): : 923 - 925
  • [26] Synthesis and in vitro anticoagulant activity of 3-(1H-imidazo[4,5-c]pyridin-2-yl)-1,5-diarylpyridin-2(1H)-one derivatives
    Yang, Jiabin
    Su, Guoqiang
    Ren, Yu
    Chen, Yang
    RESEARCH ON CHEMICAL INTERMEDIATES, 2015, 41 (11) : 8773 - 8783
  • [27] Design and synthesis of 2-amino-6-(1H, 3H-benzo[de]isochromen-6-yl)-1,3,5-triazines as novel Hsp90 inhibitors
    Suda, Atsushi
    Kawasaki, Ken-ichi
    Komiyama, Susumu
    Isshiki, Yoshiaki
    Yoon, Dong-Oh
    Kim, Sung-Jin
    Na, Young-Jun
    Hasegawa, Kiyoshi
    Fukami, Takaaki A.
    Sato, Shigeo
    Miura, Takaaki
    Ono, Naomi
    Yamazaki, Toshikazu
    Saitoh, Ryoichi
    Shimma, Nobuo
    Shiratori, Yasuhiko
    Tsukuda, Takuo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (02) : 892 - 905
  • [28] Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino) pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies
    Tong, Lexian
    Song, Pinrao
    Jiang, Kailong
    Xu, Lei
    Jin, Tingting
    Wang, Peipei
    Hu, Xiaobei
    Fang, Sui
    Gao, Anhui
    Zhou, Yubo
    Liu, Tao
    Li, Jia
    Hu, Yongzhou
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 173 : 44 - 62
  • [29] Synthesis of Novel 4-[1-(3-Chlorophenyl)-3-(pyren-1-yl)-1H-pyrazol-4-yl]-2-alkyloxy-6-substituted pyridine-3-carbonitriles
    Khalifa, N. M.
    Al-Omar, M. A.
    Taha, M. M.
    RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2017, 87 (12) : 2966 - 2969
  • [30] Scaffold Hopping-Driven Optimization of 4-(Quinazolin-4-yl)-3,4-dihydroquinoxalin-2(1H)-ones as Novel Tubulin Inhibitors
    Jiang, Li
    Goto, Masuo
    Zhu, Dong-Qing
    Hsu, Pei-Ling
    Li, Kang-Po
    Cui, Mutian
    He, Xiaoyang
    Morris-Natschke, Susan Lynne
    Lee, Kuo-Hsiung
    Xie, Lan
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (01): : 83 - 89
12345